Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Organ Transplantation, Ministry of Education, Ministry of Public Health, Chinese Academy of Medical Sciences, Wuhan, China.
Cardiorenal Med. 2020;10(6):470-475. doi: 10.1159/000510916. Epub 2020 Sep 28.
With the global spread of SARS-Cov-2 infections, increasing numbers of COVID-19 cases have been reported in transplant recipients. However, reports are lacking concerning the treatment and prognosis of COVID-19 pneumonia in renal transplant recipients with acute cardiorenal syndrome. We report here the complete clinical course of a renal transplant recipient with critical COVID-19 pneumonia. In the early phase of SARS-Cov-2 infection, the patient exhibited extensive lung lesions and significant acute kidney and heart injuries, which required treatment in the ICU. After correcting the arrhythmia and heart failure, the patient recovered quickly from the acute kidney injury with a treatment of intensive diuresis and strict control of fluid intake. Without cessation of oral immunosuppressive agents, the patient presented a delayed and low antibody response against SARS-Cov-2 and reappeared positive for the virus twice after being discharged. Nevertheless, the patient's pneumonia continued to improve and he fully recovered in 69 days. This effectively treated case may be meaningful and referable for the treatment of COVID-19 pneumonia in other transplant recipients with acute cardiorenal syndrome.
随着 SARS-CoV-2 感染在全球范围内的传播,越来越多的 COVID-19 病例在移植受者中报告。然而,关于急性心肾综合征的肾移植受者 COVID-19 肺炎的治疗和预后的报告却很少。我们在此报告了一名患有重症 COVID-19 肺炎的肾移植受者的完整临床病程。在 SARS-CoV-2 感染的早期阶段,患者表现出广泛的肺部病变和严重的急性肾和心脏损伤,需要在 ICU 治疗。在纠正心律失常和心力衰竭后,患者通过强化利尿和严格控制液体摄入,急性肾损伤迅速恢复。在未停止口服免疫抑制剂的情况下,患者对 SARS-CoV-2 的抗体反应延迟且低,并在出院后两次病毒检测再次呈阳性。然而,患者的肺炎继续改善,69 天后完全康复。这一有效治疗的病例对于治疗急性心肾综合征的其他移植受者的 COVID-19 肺炎可能具有重要意义和参考价值。